The Banksters

0x3…6f4

ERC721

Stamford, Conn.-based hedge fund advisory firm CR Intrinsic Investors, an affiliate of S.A.C. Capital, agreed to pay more than $600 million to settle SEC charges that it participated in an insider trading scheme involving a clinical trial for an Alzheimer's drug being jointly developed by two pharmaceutical companies. For more info visit https://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171513308

Name

1277

Owner

0xd5a9C4a92dDE274e126f82b215Fccb511147Cd8e

ID#1277

Rarity

X-HI:12%